MEDICAMEQ302.00

Medicamen Biotech Limited

· Pharma & Health
₹ CrorePeersMEDICOAAREYDRUGSNECLIFEHALEOSLABSALBERTDAVDNATCAPSUQVALIANTLABBALPHARMAMcap ₹410 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation7.17.17.2
+ Finance Costs4.43.23.5
+ Other Non-cash Items0.00.00.0
Changes in Working Capital
+ Inventories-14.3-2.8-7.9
+ Trade Receivables — Current10.0-13.7-12.9
+ Other Financial Assets — Current0.00.01.0
+ Other Financial Assets — Non-current0.00.0-3.7
+ Other Current Assets5.21.8-9.8
+ Other Non-current Assets-20.0-2.1-14.0
+ Trade Payables — Current-2.23.8-2.6
+ Other Current Liabilities0.2-9.11.0
+ Other Non-current Liabilities0.00.00.0
+ Provisions — Current0.0-4.1-3.1
Cash from Operating Activities
Profit Before Tax (per I/S)13.19.912.012.4
+ Total Adjustments (incl. Working Capital)-9.7-15.8-41.4
Cash from Operations (pre-tax)3.4-6.0-29.4
+ Interest Received — Operating-0.70.5-1.7
+ Other Inflows / (Outflows) — Operating0.0-0.40.0
+ Income Taxes Paid3.11.42.0
Cash from Operating Activities-0.4-7.2-33.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.02.14.8
+ Acq of Intangible Assets6.30.00.0
+ Acq of Other Long-term Assets0.00.30.0
+ Interest Received — Investing0.70.51.7
Cash from Investing Activities-5.6-1.9-3.0
Cash from Financing Activities
+ Proceeds from Issue of Shares0.10.90.8
+ Proceeds from Other Equity Instruments1.80.052.7
+ Payments for Other Equity Instruments2.90.00.0
+ Proceeds from Borrowings6.21.614.5
+ Repayment of Borrowings-0.40.00.0
+ Interest Paid4.43.23.5
+ Dividends Paid1.31.31.4
+ Other Inflows / (Outflows) — Financing0.00.00.5
Cash from Financing Activities-0.1-1.963.7
Net Changes in Cash (pre-FX)-6.0-11.027.5
Net Changes in Cash-6.0-11.027.5
Closing Cash14.8
Reference Items
EBITDA22.213.919.619.3
EBITDA Margin %12.408.539.909.52
Free Cash Flow (CFO − Capex)-6.7-9.3-38.0-38.0
Free Cash Flow to Equity-10.0-26.9
Free Cash Flow per Basic Share-4.91-6.83-27.98-27.98
Cash Flow to Net Income-0.04-1.10-3.39
Cash Paid for Taxes3.11.42.0
Cash Paid for Interest4.43.23.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.